Sensible Biotechnologies Slashes Time Taken to Optimize Novel Cell-Based mRNA Therapeutics by More Than 90% with AI Platform Built on NVIDIA Technology
Sensible Biotechnologies, a biotechnology company pioneering a cell-based platform for the design and manufacturing of mRNA therapeutics, today announced an initiative to accelerate the development of next-generation mRNA medicines through AI-driven molecular design powered by NVIDIA accelerated computing and AI.
